[Psoriasis SCID-mouse model]
- PMID: 16028077
- DOI: 10.1007/s00105-005-0990-x
[Psoriasis SCID-mouse model]
Abstract
Psoriasis is characterized by a complex phenotype and pathogenesis along with polygenic determination. Several psoriasis animal models have only been able to incompletely reproduce the disease. A xenogeneic transplantation approach, grafting skin from psoriatic patients onto mice with a severe combined immunodeficiency (SCID), was the first to meet the criteria for a psoriasis model. During the last 10 years, this psoriasis SCID-mouse model not only allowed telling experiments focusing on pathogenetic aspects, but also proved being a powerful tool for drug discovery with a good predictive value.
Similar articles
-
Anti-CD11a ameliorates disease in the human psoriatic skin-SCID mouse transplant model: comparison of antibody to CD11a with Cyclosporin A and clobetasol propionate.Lab Invest. 2001 Sep;81(9):1253-61. doi: 10.1038/labinvest.3780339. Lab Invest. 2001. PMID: 11555673
-
Xenotransplantation Model of Psoriasis.Methods Mol Biol. 2017;1559:83-90. doi: 10.1007/978-1-4939-6786-5_7. Methods Mol Biol. 2017. PMID: 28063039
-
[Psoriasis in the animal model].Hautarzt. 1997 Oct;48(10):707-13. doi: 10.1007/s001050050648. Hautarzt. 1997. PMID: 9441162 Review. German.
-
Translating clinical activity and gene expression signatures of etanercept and ciclosporin to the psoriasis xenograft SCID mouse model.Br J Dermatol. 2012 Mar;166(3):649-52. doi: 10.1111/j.1365-2133.2011.10713.x. Epub 2012 Jan 19. Br J Dermatol. 2012. PMID: 22050597
-
Severe combined immunodeficiency mouse-human skin chimeras: a unique animal model for the study of psoriasis and cutaneous inflammation.Br J Dermatol. 2001 May;144(5):931-9. doi: 10.1046/j.1365-2133.2001.04178.x. Br J Dermatol. 2001. PMID: 11359377 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical